About BioMedomics
BioMedomics is a Technology company based in Durham (United States) founded in 2006. Point-of-care diagnostic systems for blood-based disorders are developed. It operates in the Technology and Healthcare sectors. BioMedomics has raised $1.5 million across 6 funding rounds from investors including NIH and HHS. BioMedomics offers products and services including Sickle SCAN, Sickle SCAN EZ, and Infectious Disease Tests. Its focus areas include High Tech, Nanotechnology, Nanoenabled Products and Life Science. Its legal entity is BIOMEDOMICS, INC. Its competitors include Entopsis and Hemex Health; 2 of its 2 listed competitors have raised funding.
Company details
BioMedomics was founded in 2006 in Durham, United States, within the biotechnology sector. Point-of-care diagnostic systems for blood-based disorders are created using proprietary time-resolved lateral flow immunoassay technology and a nanotube-based platform. Operations focus on assays that have received CE marking for sickle cell anemia, hemoglobin measurement, and alpha-thalassemia detection.
- Total Equity Funding$1.5M (USD)
in 6 rounds
- InvestorsNIH
& 1 more
Products & Services of BioMedomics
BioMedomics offers a comprehensive portfolio of products and services, including Sickle SCAN, Sickle SCAN EZ, and Infectious Disease Tests.
Rapid point-of-care test for sickle cell disease detection
Simplified test for large-scale sickle cell diagnostics
Tests for identifying pathogens and microorganisms
Apps and channels of BioMedomics
its YouTube channel Biomedomics Inc has 306 subscribers and 7 videos.
Videos from BioMedomics
The most watched videos on BioMedomics's YouTube channel, Biomedomics Inc (306 subscribers). Click a video to play it here.
More on Biomedomics Inc.
Funding Insights of BioMedomics
BioMedomics has successfully raised a total of $1.5M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.5M
- Total Rounds 6
- First Round $690,000
(Jan 2014)
- Investors Count 2
All 6 funding rounds of BioMedomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in BioMedomics
BioMedomics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for BioMedomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioMedomics
5 people are tracked at BioMedomics (3 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Gulam Killasama | Head Of Sales And Marketing For African | Leadership |
Dia A. | Market Access Partner | Leadership |
Frank Wang | CEO | Leadership |
Wael Ghannam | Channel Sales Manager | Team |
Dr Poubom Rayban | Sales And Marketing Specialist | Team |
Complete people profiles for BioMedomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioMedomics
3 dated milestones of BioMedomics across 11 years, from founding to its latest funding, stage changes and deals.
- Founded BioMedomics is founded.
- Funding First funding round of $690K.
- Funding Latest funding round, Debt – Conventional,.
Competitors of BioMedomics
BioMedomics has 2 listed competitors in our database, 2 of them funded. They include Entopsis and Hemex Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| entopsis.com | 2011 | Miami, United States | $1.05M | Diagnostic devices for health monitoring are developed using specialized slides. | ||
| hemexhealth.com | 2016 | Portland, United States | $6.24M | 33 | Platform providing care devices for the detection of tropical diseases |
Detailed competitors of BioMedomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioMedomics
The website of BioMedomics (biomedomics.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 464% vs previous month
Top companies in Nanotechnology
3 companies that operate in the same segment as BioMedomics (Nanotechnology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biomedomics
Complete news archive for BioMedomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioMedomics
BioMedomics was founded in 2006 and raised its 1st funding round 8 years after it was founded.
BioMedomics is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
BioMedomics is a funded company, having raised a total of $1.5M across 6 funding rounds to date. The company's 1st funding round was a Seed of $690K, raised on Jan 2014.
BioMedomics was founded in 2006 in Durham, United States, within the biotechnology sector. Point-of-care diagnostic systems for blood-based disorders are created using proprietary time-resolved lateral flow immunoassay technology and a nanotube-based platform. Operations focus on assays that have received CE marking for sickle cell anemia, hemoglobin measurement, and alpha-thalassemia detection.
BioMedomics's top competitors include Hemex Health and Entopsis.
BioMedomics offers Sickle SCAN, Sickle SCAN EZ, and Infectious Disease Tests.
BioMedomics operates through Biomedomics, Inc..